Phoenix Holdings Ltd. Sol Gel Technologies Ltd. Transaction History

Phoenix Holdings Ltd.

$7.18 Billion
Q4 2024

A detailed history of Phoenix Holdings Ltd. transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Phoenix Holdings Ltd. holds 2,470,192 shares of SLGL stock, worth $1.46 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,470,192

Previous 2,470,192 -0.0%

Holding current value

$1.46 Million

Previous $1.68 Million 36.81%

% of portfolio

0.03%

Previous 0.03%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.66 - $1.05 $69,121 - $109,966	-104,730 Reduced 4.07%	2,470,192 $2.2 Million
Q4 2021 Feb 07, 2022	SELL	$6.57 - $9.78 $238,169 - $354,534	-36,251 Reduced 1.39%	2,574,922 $19.1 Million
Q3 2021 Oct 27, 2021	SELL	$8.85 - $12.5 $1,955 - $2,762	-221 Reduced 0.01%	2,611,173 $26.1 Million
Q2 2021 Aug 10, 2021	BUY	$9.53 - $14.7 $795,812 - $1.23 Million	83,506 Added 3.3%	2,611,394 $32.3 Million
Q1 2021 May 10, 2021	SELL	$8.75 - $15.49 $1.27 Million - $2.25 Million	-145,056 Reduced 5.43%	2,527,888 $31.3 Million
Q4 2020 Feb 11, 2021	SELL	$7.11 - $9.99 $197,985 - $278,181	-27,846 Reduced 1.03%	2,672,944 $26.1 Million
Q3 2020 Nov 10, 2020	SELL	$7.15 - $8.73 $7,557 - $9,227	-1,057 Reduced 0.04%	2,700,790 $18.4 Million
Q1 2020 May 20, 2020	BUY	$5.88 - $15.75 $3.48 Million - $9.33 Million	592,068 Added 28.06%	2,701,847 $18.6 Million
Q4 2019 Feb 18, 2020	BUY	$7.5 - $17.15 $545,115 - $1.25 Million	72,682 Added 3.57%	2,109,779 $35.9 Million
Q3 2019 Nov 18, 2019	BUY	$7.7 - $10.48 $15.7 Million - $21.3 Million	2,037,097 New	2,037,097 $17.5 Million

Others Institutions Holding SLGL

# of Institutions

Shares Held

5.31M

Call Options Held

12.8K

Put Options Held

View Full List

About Sol-Gel Technologies Ltd.

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $13.6M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

More about SLGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.

Account

Phoenix Holdings Ltd. Sol Gel Technologies Ltd. Transaction History